On the interaction of vanadium species with meso-2,3-dimercaptosuccinic acid

Biological Trace Element Research

Volumn 109, Issue 2, 2006, Pages 189-194

  Williams, P A M ^a   Baran, E J ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

2,3 Dimercaptosuccinic acid; Electronic spectra; Interactions; Oxovanadium(IV); Vanadium (V); Vanadium detoxification

Indexed keywords

ACID; SUCCIMER; VANADIUM;

AQUEOUS SOLUTION; ARTICLE; CHELATION; COMPLEX FORMATION; NONHUMAN; PH; PROTON TRANSPORT; SPECIES IDENTIFICATION; SPECTROPHOTOMETRY; SPECTROSCOPY; STRUCTURE ANALYSIS; SUSPENSION; TITRIMETRY;

CHELATING AGENTS; DRUG INTERACTIONS; METABOLIC DETOXICATION, DRUG; OXIDATION-REDUCTION; SPECTROSCOPY, ELECTRON ENERGY-LOSS; SUCCIMER; VANADATES; VANADIUM;

EID: 31544441958     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:109:2:189     Document Type: Article

References (16)

1. D. M. Taylor and D. R. Williams, Trace Element Medicine and Chelation Therapy, Royal Society of Chemistry, Cambridge (1995).
2. O. Andersen, Principles and recent development in chelation treatment of metal intoxication, Chem. Rev. 99, 2683-2710 (1999).
3. O. Andersen, Chemical and biological considerations in the treatment of metal intoxications by chelating agents, Mini-Rev. Med. Chem. 4, 11-21 (2004).
4. E. J. Baran, Quíamica Bioinorgánica, McGraw-Hill Interamericana de España, Madrid (1995).
5. D. M. Aposhian, R. M. Maiorino, D. González-Ramírez, et al., Mobilization of heavy metals by newer, therapeutically useful chelating agents, Toxicology 97, 23-38 (1995).
6. E. J. Baran, Model studies related to vanadium biochemistry: recent advances and perspectives, J. Braz. Chem. Soc. 14, 878-888 (2003).
7. V. Baran and E. J. Baran, Contaminación atmosférica por vanadio: importancia de su monitoreo y control, An. Acad. Nac. Cs. Ex. Fís. Nat. 54, 171-177 (2002).
8. E. J. Baran, Vanadium detoxification, in Vanadium in the Environment. Part 2: Health Effects, J. O. Nriagu, ed., Wiley, New York, pp. 317-345 (1998).
9. H. Sakurai, S. Shimomura, and K. Ishizu, Reduction of vanadate (V) to oxova-nadium (IV) by cysteine and mechanism and structure of the oxovanadium (IV)-cysteine complex subsequently formed, Inorg. Chim. Acta 55, L67-L69 (1981).
10. 2+/glutathione interactions, Biol. Trace Element Res. 30, 175-183 (1991).
11. J. Li, G. Elberg, D. C. Crans, and Y. Schechter, Evidence for the distinct vanadyl(+4) dependent activating system for manifesting insulin-like effects, Biochemistry 35, 8314-8318 (1996).
12. C. Duval, Inorganic Thermogravimetric Analysis, Elsevier, Amsterdam (1963).
13. P. A. M. Williams, D. A. Barrio, and S. B. Etcheverry, Interactions of vanadyl (IV) with dithiothreitol and thioglycolic acid. Their action on alkaline phosphatase activity, J. Inorg. Biochem. 75, 99-104 (1999).
14. B. J. McCormick, The structure and spectra of dithiocarbamate complexes of oxovanadium(IV), Inorg. Chem. 7, 1965-1970 (1968).
15. C. I. Muglia and E. J. Baran, Vibrational spectrum of bis(pyrrolidine-N-carbodithioato)oxovanadium(IV): a new insulin-mimetic vanadyl complex, Acta Farm. Bonaerense 19, 21-24 (2000).
16. K. A. Connors, Binding Constants, Wiley, New York (1981).